Clinical Trial on the Efficacy of Intralesional Triamcinolone Versus Candida Albicans Antigen in Treating Alopecia Areata

NCT06564805 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Alopecia Areata

Interventions

DRUG: Candida Albicans Antigen Injection

Sponsor

Universidad Autonoma de Nuevo Leon